Dr. John J. Cuaron, MD

Dr. Cuaron practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Cuaron's NPI, 1275844193, was assigned on June 24, 2010. Dr. Cuaron graduated from Boston University School Of Medicine in 2010. Dr. Cuaron holds New York license 261921.

Dr. Cuaron's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Cuaron's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Cuaron to 6 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cuaron practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Cuaron's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Cuaron is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Cuaron's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and lung cancer radiation among the conditions Dr. Cuaron treats.

CMS data shows 3,042 Medicare services from Dr. Cuaron across 15 procedure codes in 2024, for 402 Medicare patients. Medicare paid $225,305 for them.

CMS counts 402 Medicare patients who saw Dr. Cuaron in 2024. The largest group is 65 to 74, with 182 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cuaron's median patient age at 70, with 73% women.

In 2024, Dr. Cuaron wrote 156 Medicare Part D claims for 101 patients. 89% of them were for generic drugs. CMS names the drug for 78 of them, across 2 drugs with 11 or more claims each, at $1,882 in total drug cost. In 2023, CMS named 73 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Cuaron for performance year 2024, reported as part of a group. Dr. Cuaron accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cuaron as offering telehealth.

Dmand AI links 54 papers to Dr. Cuaron, published from 2009 to 2024. 2024 was the busiest year, with 10. The most frequent topics are Breast Neoplasms, Pancreatic Neoplasms and Radiotherapy Planning, Computer-Assisted. Dr. Cuaron has published most often in Int J Radiat Oncol Biol Phys. Dr. Cuaron's most frequent co-authors are Abraham Jing-Ching Wu, MD, Marsha Reyngold, MD, PhD and Boris A. Mueller, MD.

CMS Open Payments shows 1 general payment to Dr. Cuaron from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Tempus AI, Inc paid the most, $29.

Dr. Cuaron graduated from Boston University School Of Medicine in 2010.

Dr. Cuaron is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.